Monday, 30 July 2012

Lab Notes: Anemia Drugs Yield Big Profits, Few Benefits

On our Lab Notes page CalorieLab’s editors select and rank the day’s essential health news items in real time. Readers can suggest, vote and comment on items. Below are brief summaries of yesterday’s (July 22, 2012) Lab Notes items. To see today’s items, visit Lab Notes.

1. Anemia Drugs Yield Big Profits, Few Benefits

Anemia drugs Epogen, Procrit and Aranesp, which have generated over $8 billion a year for more than 20 years for Amgen and Johnson & Johnson, provide nowhere near the benefits the makers claim, and have side-effects that include strokes and cancer.

(By CalorieLab editors)

Lab Notes: Anemia Drugs Yield Big Profits, Few Benefits is a post from: CalorieLab - Health News & Information Blog

Source: http://calorielab.com/news/2012/07/23/yesterdays-health-news-from-labnotes-839/

mediterranian diet milk diet flat belly diet how to lose weight fast herbal life diet

No comments:

Post a Comment